from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3569c/hsaD

LFCtreatmentdescriptionclass of inhibitor

-0.547

Amikacinug/mL Amikacintranslation

-1.310

Cap5-10ug/mL Capreomycintranslation

-2.339

Rox10-50 ug/mL Roxithromycintranslation

-0.088

SM2-5 ug/mL Streptomycintranslation

-0.445

Tet5-10 ug/mL Tetracyclinetranslation

1.058

Rif0.2-5ug/mL Rifampicintranscription

-0.763

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.305

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.377

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.137

CPZ10-50 ug/mL Chlorpromazinerespiration

1.144

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.167

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.646

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.716

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.212

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.248

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.042

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.766

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.180

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.225

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.106

KCN5-20 ug/mL Potassium cyaniderespiration

-0.559

NaN30.2-2 mM Sodium aziderespiration

-0.977

Nigericin50 uM Nigericinrespiration

0.583

TRC10-150 ug/mL Triclosanrespiration

2.957

TRZ10-25 ug/mL Thioridazinerespiration

0.135

Valinomycin0.5-10 uM Valinomycinrespiration

-1.266

ZnSO42 mM ZnSO4respiration

0.073

menadione6-10 ug/mL Menadionerespiration

2.458

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.503

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.304

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.064

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.149

NRP_1Non-replicating persistence stage 1dosRassociated

-0.412

Amp0.2mg/mL AmpicillincellWall

-0.564

Cephalexin20-100 ug/mL CephalexincellWall

-0.533

Cerulenin0.32-5 ug/mL CerulenincellWall

1.154

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.559

EMB10-20 ug/mL EthambutolcellWall

-0.368

Eta12-40 ug/mL EthionamidecellWall

-0.482

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.344

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.884

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.958

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.169

BZA0.12 mg/mL BenzamidearomaticAmides

-0.105

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.408

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.178

H2O24 mM hydrogen peroxideDNAdamaging

-0.648

Levo10 ug/mL LevofloxacinDNAdamaging

-0.214

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.440

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.342

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.492

UVUV-irradiationDNAdamaging

-0.391

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.039

Antimycin12.5-50 ug/mL Antimycin A?

-1.226

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.554

PA_110-50 ug/mL Antitubercular compound PA-1?

0.584

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.229

PA8240.2-2 ug/mL PA-824?

0.037

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.249

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.305

Verapamil50 uM Verapamil?

-1.124

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.142

methoxatin10-20 ug/mL Methoxatin?